Pulmonology
COPD
More in COPD
Prices went down but reductions in new oxygen prescriptions and discontinuations were minimal
Oct 28, 2024
Phase III trial program showed 30% to 34% reduction in moderate or severe exacerbations
Sep 27, 2024
They'll "still have that ball and chain, but maybe we've lightened it a little bit," says expert
Sep 10, 2024
0.75
CME Credits